- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
Purpose Bitcoin ETF
Silver47 Exploration
Syntheia
CI Galaxy Bitcoin ETF
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Canopy said the deal “lays the groundwork” for future CBD-infused product offerings in the sport food and hydration sectors in the US.
Canopy Growth (NYSE:CGC,TSX:WEED) is positioning itself to take on the cannabidiol (CBD)-infused sport nutrition industry.
The Canadian cannabis giant confirmed on Wednesday (October 2) that it has completed a majority stake purchase of BioSteel Sports Nutrition, a producer of sport and hydration supplements.
The all-cash transaction gives the Ontario-based cannabis producer a 72 percent stake in BioSteel, with the understanding that Canopy Growth will move toward full ownership later in the future. The financial terms of the deal have not yet been disclosed.
The company said the deal “lays the groundwork” for future CBD-infused product offerings in the sport food and hydration sectors in the US, using federally permissible CBD sourced from hemp.
Paradigm Capital and McCarthy Tétrault acted as BioSteel’s financial advisor and legal counsel, respectively, during the transaction.
Canopy Growth CEO Mark Zekulin said in a statement that the transaction will help further the company’s goal of moving into the CBD food and beverage space.
“We view the adoption of CBD in future BioSteel offerings as a potentially significant and disruptive growth driver for our business,” he said.
In a TSN interview, Zekulin said the company could offer CBD-infused sports drinks as soon as next year.
The deal will also give Canopy Growth an entry point into the global sport nutrition market, which is expected to reach US$24.4 billion by 2025, according to data from Grand View Research.
On the CBD front in the US, the firm received a New York hemp license at the beginning of the year, and in July, the company unveiled its hemp processing plant in the state. Canopy Growth is also developing a line of CBD products with television personality Martha Stewart, to be released in mid-2020.
For its part, BioSteel offers a selection of hydration drinks, protein powders and other products to athletes in professional sports, and has over 10,000 points of distribution in Canada and the US. BioSteel also has plans to break into the European market.
Since its founding in 2009, BioSteel’s products have been bought by more than 70 percent of the teams in North America’s four major leagues.
The Toronto-based sport nutrition company is bringing with it sponsorships from professional athlete standouts, including Dallas Cowboys running back Ezekiel Elliott, Connor McDavid of the Edmonton Oilers, pro golfer Eugenie Bouchard and National Hockey League (NHL) hall-of-famer Wayne Gretzky.
As a part of the transaction, former NHL star and BioSteel co-founder Michael Cammalleri will assume the full-time role of co-CEO alongside sport nutrition executive John Celenza, according to TSN.
In a statement, Celenza noted that the deal will help BioSteel expand its global distribution while enhancing its current product portfolio.
“The consumer market and many of our athletes have a growing knowledge of cannabis and CBD products and this partnership ensures that we will continue to raise the bar in the sports nutrition field.”
Canopy Growth’s share price opened at C$27.98 on Wednesday and, as of 12:40 p.m. EDT, the company sat at C$28.69, an increase of 2.5 percent in value.
Earlier this year, the cannabis firm paired up with the NHL Alumni Association to research the effect of cannabinoids on post-concussion neurological diseases in former hockey players.
Don’t forget to follow us @INN_Cannabis for real-time news updates!
Securities Disclosure: I, Danielle Edwards, hold no direct investment interest in any company mentioned in this article.
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.